10x Genomics, Inc. — Director's Dealing 2020

Jan 7, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2020-01-03

Reporting Person: Hindson Benjamin J. (Director, See Remarks, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-03	Class A Common Stock	M	67500	$0.88	Acquired	67500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-03	Stock Option (right to buy)	$0.88	M	67500	Disposed	2025-10-27	Class A Common Stock (67500)	Direct

Footnotes

F1: All of the shares subject to the option are fully vested and exercisable as of the date hereof.